placeholder image

Y. Huang All authors

About

Publications While At HealthPartners

selected publications

Journal Article
  • Effect of intrawound vancomycin powder in operatively treated high-risk tibia fractures: a randomized clinical trial. 
  • Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study. 
  • Durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer. 
  • Erlotinib, cabozantinib, or erlotinib plus cabozantinib as second-line or third-line treatment of patients with EGFR wild-type advanced non-small-cell lung cancer (ECOG-ACRIN 1512): a randomised, controlled, open-label, multicentre, phase 2 trial. 
  • Biomarker-calibrated dietary energy and protein intake associations with diabetes risk among postmenopausal women from the Women's Health Initiative. 

    • Contact

    full name

  • Y. Huang

    • Quick Info

    Publications

    Collaboration